- Peer Review Policy
- Ethics and Publication Malpractice Statement
- Conflict of Interest
- Patient Consent
Aims and Scope of ACNR
Advances in clinical neuroscience & rehabilitation (Print) ISSN 1473-9348
Advances in clinical neuroscience & rehabilitation (Online) ISSN 2397-267X
ACNR (Advances in Clinical Neuroscience and Rehabilitation) is a peer reviewed open access neurology journal, based in the UK and with international readership. ACNR aims to keep busy practicing neurologists and rehabilitation specialists up-to-date with the latest advances in their fields, including areas of neurology and neuroscience outside their main area of sub-specialty interest.
The major content of ACNR is short reviews commissioned independently from leading UK and international experts. There is a focus on emerging knowledge about clinical neuroscience, neurology, rehabilitation and therapeutics, as well as evidence-based analysis of neurological practice – often in areas where definitive evidence and consensus is lacking.
ACNR prioritises review articles, but will consider original research articles where appropriate. Please contact the Publisher Rachael Hansford with any pre-submission enquiries.
ACNR was launched in 2001 as an open access neurology journal by Rachael Hansford under the name of Whitehouse Publishing, with the support of Roger Barker, Alasdair Coles and Stephen Kirker.
With a background in medical publishing, Rachael was inspired to launch a neurology journal because of her brother’s significant brain injuries. This personal commitment over nearly two decades, combined with the dedication of the specialists who have given so freely of their time and expertise, has helped ACNR to become one of the best read publications in the neurology field in the UK.
The print version is distributed four times a year to 4,000 UK readers, including all of the UK’s Consultant Neurologists, plus Consultant Rehabilitation Specialists, Trainees, Neuroscientists and Allied Health professionals. Our email newsletter, with links to all the open access content online, has 3,400 subscribers world-wide.
We also have an additional 650 neurology specialist email subscribers in Australia and New Zealand, and commission articles from the region via our Editor in Australia, Todd Hardy.
Open Access Statement
ACNR is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
Instructions for Authors
You can find our instructions for authors here.
How is ACNR Funded?
We are able to provide ACNR as an open access neurology journal thanks to the support of advertisers. However, the editorial is peer reviewed and remains completely independent. Decisions about content are made by the editorial team, who are not involved in generating advertising revenue or sponsorship. Advertising is managed by the Publisher.
We accept advertisements and sponsored editorial from pharmaceutical companies and other companies supplying products relevant to the field. Sponsored content is clearly identified as such.
There are no publication charges for authors who contribute to ACNR, or for their institutions. If you are interested in contributing an article, please read our Instructions for authors
In order to keep ACNR Open Access, we may infrequently send subscribers news from our sponsors which is relevant to the field of neurology. While we hope readers will stay and enjoy all of our free content, there is an unsubscribe link at the bottom of all our emails which easily removes contact details from our database.
Policies and Forms
ACNR is published in accordance with the core practices outlined by the Committee on Publication Ethics (https://publicationethics.org/)
- Ethics and Publication Malpractice
Read our Ethics and Publication Malpractice Statement.
- Peer Review Policy
- Conflict of Interest Form
Authors are responsible for disclosing all conflicts of interest in their manuscript including financial, consultant, institutional, personal and other relationships between themselves and others that might bias their work. Download form here.
- Patient Consent Form
Forms must be completed where appropriate. Download here.
Todd Hardy, BSc (Hons 1), PhD, MBBS, FRACP is Co-Editor of ACNR and is a Staff Specialist Neurologist at Concord Repatriation General Hospital, Clinical Associate Professor at the University of Sydney, and Co-Director of the MS Clinic at the Brain and Mind Centre. His main interests are multiple sclerosis and other immune-mediated central nervous system disorders.
Ann Donnelly MB ChB BSc (Clin Neurosci) MRCP is Co-Editor of ACNR and a Consultant in Neurology at the Royal Free Neurological Rehabilitation Centre. She completed undergraduate training at University of Glasgow Medical School, with Neurology postgraduate training at Kings College Hospital, National Hospital for Neurology and Neurosurgery, and Guys and St Thomas’ Hospital. She is interested in neurorehabilitation with a focus on patients with multiple sclerosis.
Kirstie Anderson, BMedSci, MBBS, MRCP, DPhil (Oxon), is ACNR’s Sleep Editor. She runs the Regional Neurology Sleep Service with a clinical and research interest in all the sleep disorders. She is an Honorary Senior Lecturer at Newcastle University with an interest in the link between sleep and mental health.
Roger Barker MRCP, PhD, F.Med.Sci. is Consulting and Founding Editor of ACNR, Professor of Clinical Neuroscience, University of Cambridge and an Honorary Consultant Neurologist at the Cambridge Centre for Brain Repair, Cambridge, UK. His main area of research is into neurodegenerative and movement disorders, in particular Parkinson’s and Huntington’s disease.
Alasdair Coles PhD is Consulting and former Co-Editor of ACNR. He is a Professor of Neuroimmunology at Cambridge University. He works on experimental immunological therapies in multiple sclerosis.
Rhys Davies MA, BMBCh, PhD, MRCP is the Editor of our Book Review Section. He is a consultant neurologist at the Walton Centre for Neurology and Neurosurgery in Liverpool and at Ysbyty Gwynedd in Bangor, North Wales. He has a clinical and research interest in cognitive neurology.
Rosemary Fricker PhD, FHEA is an ACNR Series Editor. She is currently Visiting Professor of Neurobiology at Keele University, and the former Director of Medical Science at Keele Medical School. She graduated with a PhD in Neuroscience from Cambridge University and her areas of research are in developing cell replacement therapies for neurodegenerative disease, stem cells, and the role of vitamins in neuronal development and neural repair.
Manoj Sivan, MD, FRCP, is the Editor of our Pain and Rehabilitation Section and is an Associate Clinical Professor and Honorary Consultant in Rehabilitation Medicine (RM) with University of Leeds and Leeds Teaching Hospitals and an Honorary Senior Lecturer in the Human Pain Research Group with University of Manchester. His research interests are pain medicine, rehabilitation technology, chronic conditions and outcome measurement.
Dr Emily Thomas, BmBCh, MRCP, PhD is ACNR’s Rehabilitation Editor. She is a Consultant in Rehabilitation working for Solent NHS Trust, Southampton. Her main interests are holistic brain injury rehabilitation and spasticity management.
David Werring FRCP, PhD, FESO is ACNR’s Stroke Editor. He is Professor of Clinical Neurology at UCL Institute of Neurology, Queen Square, and Honorary Consultant Neurologist at University College Hospital and The National Hospital, Queen Square, London.
Peter Whitfield BM (Distinction in Clin Med), PhD, FRCS Eng., FRCS, SN, FHEA is ACNR’s Neurosurgery Editor. He is a Consultant Neurosurgeon at the South West Neurosurgery Centre, Plymouth. His clinical interests are wide including neurovascular conditions, head injury, stereotactic radiosurgery, image guided tumour surgery and lumbar microdiscectomy. He is an examiner for the MRCS and is a member of the SAC in neurosurgery.
Alastair Wilkins PhD is our Case Report Co-ordinator. He is Reader in Neurology, University of Bristol and Consultant Neurologist at North Bristol NHS Trust. His research interests are the basic science of axon degeneration and developing treatments for progressive multiple sclerosis.
Dr Michael Zandi MA MB BChir PhD FRCP is a Consulting and former Editor of ACNR. He is Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square and UCLH, London. He is Honorary Associate Professor in the University College London Queen Square Institute of Neurology Department of Neuromuscular Diseases.
Angelika Zarkali MBBS (Hons), MRCP, is the Editor of our Conference News section. She is a Specialist Registrar in Neurology in Kent Surrey and Sussex Deanery and has an interest in neurodegeneration and cognitive disorders.